Drug Development Bolstered by Hope, Innovation and Science

Drug Development Bolstered by Hope, Innovation and Science.

For centuries, the desire to end human suffering inflicted by disease has sparked compassion, curiosity, and decades of research and drug development. It has pushed a relentless pursuit for answers, inspired bold thinking, and driven an unfaltering will to prevail in the face of daunting odds.

While answers don’t come easily, Genzada Pharmaceuticals is driven by hope and something more—remarkable science. We’re proud to be part of a global community of physicians, scientists, chemists, clinicians, pharmaceutical experts, and like-minded pioneers working on the frontier of drug development. Together, we work to create treatments that will turn the tide against some of the deadliest forms of cancer.

Our mission is rooted in an inventive mindset that fosters ground-breaking drug development. Our discoveries are the result of painstaking scientific rigor. Our novel therapeutics stem from natural compounds that boast extraordinary efficacy when precisely formulated to disrupt cancer development and progression. These discoveries may one day change patients’ lives—and the world.


More News


Genzada Pharmaceuticals Opens Phase 1B Metastatic Breast Cancer Trial

May 12, 2022

“This is a significant and exciting achievement for our company,” said Chief Operating Officer Cameron West, MD. “Our Phase 1 study demonstrated that 6.02 has…

Read More

Drug Development

First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02 from Genzada Pharmaceuticals

March 20, 2019

Genzada Pharmaceuticals USA Inc. announced today that the first patient enrolled in its Phase 1 clinical trial for the oral therapeutic GZ17-6.02 received the first…

Read More

FDA Approval

Kansas Company Receives FDA Approval on Plant Derived Cancer Treatment

November 20, 2018

More than 600,000 people are expected to die from cancer this year, according to the National Cancer Institute. However, one Kansas company in Sterling is…

Read More